At the Extremes


SC Fundamental’s David Hurwitz describes what makes today’s investment opportunity set so fertile, how he sources eclectic ideas, why he considers the balance sheet more important than the income statement, and why he’s long Doosan Corp., Dolphin Capital and Transcept Pharmaceuticals and short and Commonwealth Bank of Australia.

If you are a subscriber, log in to access the issue and bonus archive: